Fibrinogen kinetics and protein turnover in hypertension: Effects of insulin

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 11, 2009, Pages 789-796

  Kiwanuka, E ^a   Coracina, A ^a   Vettore, M ^a   Semplicini, A ^a   Zaramella, M ^a   Millioni, R ^a   Puricelli, L ^a   Baiocchi, M R ^a   Tessari, P ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Amino acid clearance; Euglycemic clamp; Fibrinogen FSR and ASR; Insulin sensitivity; Leucine; Stable isotopes

Indexed keywords

EID: 70449722924     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.01.005     Document Type: Article

References (39)

1. Wilhemsen L., Svardsuss K., and Korsan-Bengsten K. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311 (1984) 501-505
2. Grover S.A., Hemmelgarn B., Joseph L., Milot A., and Tremblay G. The role of global risk assessment in hypertension therapy. Can J Cardiol 22 (2006) 606-613
3. Catena C., Novello M., Lapenna R., Baroselli S., Colussi G., Nadalini E., et al. New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a). J Hypertens 23 (2005) 1617-1631
4. Engstrom G., Janzon L., Berglund G., Lind P., Stavenow L., Hedblad B., et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 22 (2002) 2054-2058
5. Lane J.S., Vittinghoff E., Lane K.T., Hiramoto J.S., and Messina L.M. Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey 1999-2002. J Vasc Surg 44 (2006) 319-324
6. Engstrom G., Hedblad B., Janzon L., and Lindgarde F. Fatality of acute coronary events in relation to hypertension and low-grade inflammation: a population-based cohort study. J Hum Hypertens 20 (2006) 581-586
7. Tessari P., Inchiostro S., Biolo G., Trevisan R., Fantin G., Marescotti M.C., et al. Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition. J Clin Invest 79 (1987) 1062-1069
8. De Feo P., Volpi E., Lucidi P., Cruciani G., Reboldi G., Siepi D., et al. Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes 42 (1993) 995-1002
9. Barazzoni R., Kiwanuka E., Zanetti M., Cristini M., Vettore M., and Tessari P. Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes. Diabetes 52 (2003) 1851-1856
10. Mertens I., and Van Gaal L.F. New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP-ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome. J Thromb Haemost 4 (2006) 1164-1166
11. Devaraj S., Rosenson R.S., and Jialal I. Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status. Endocrinol Metab Clin North Am 33 (2004) 431-453
12. Haller M., Akbulut C., Brechtelsbauer H., Fett W., Briegel J., Finsterer U., et al. Determination of plasma volume with indocyanine green in man. Life Sci 53 (1993) 1597-1604
13. Hoffmann J.J.M.L., and Verhappen M.A.L. Automated nephelometry of fibrinogen: analytical performance and observations during thrombotic therapy. Clin Chem 34 (1998) 2135-2140
14. Schwenk W.F., Berg P.J., Beaufrere B., Miles J.M., and Haymond M.W. Use of t-butyl-dimethylsilylation in the GC/MS analysis of physiologic compounds found in plasma using electron impact ionization. Anal Biochem 141 (1984) 101-109
15. Wolfe R.R. Radioactive and stable isotope tracers in biomedicine. Principles and practice of kinetics analysis (1992), Wiley-Liss, New York pp. 62-70
16. Schwenk W.F., Beaufrere B., and Haymond M.W. Use of reciprocal pool specific activities to model leucine metabolism in man. Am J Physiol 249 (1985) E646-E650
17. Ferrannini E., Haffner S.M., and Stern M.P. Essential hypertension: an insulin-resistant state. J Cardiovasc Pharmacol 15 Suppl. 5 (1990) S18-S25
18. Kurl S., Laukkanen J.A., Niskanen L., Laaksonen D., Sivenius J., Nyyssonen K., et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37 (2006) 806-811
19. Tessari P., Kiwanuka E., Millioni R., Vettore M., Puricelli L., Zanetti M., et al. Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. Diabetes Care 29 (2006) 323-328
20. Amagasa H., Okazaki M., Iwai S., Kumai T., Kobayashi S., and Oguchi K. Enhancement of the coagulation system in spontaneously hypertensive and hyperlipidemic rats. J Atheroscler Thromb 12 (2005) 191-198
21. Voisin L., Breuille D., Ruot B., Ralliere C., Rambourdin F., Dalle M., et al. Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats. Am J Physiol 275 (1998) R1412-R1419
22. Garanty-Bogacka B., Syrenicz M., Syrenicz A., Gebala A., Lulka D., and Walczak M. Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. Neuro Endocrinol Lett 26 (2005) 242-246
23. Pickup J.C., Mattock M.B., Chusney G.D., and Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40 (1997) 1286-1292
24. Festa A., D'Agostino Jr. R., Tracy R.P., and Haffner S.M. The Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51 (2002) 1131-1137
25. Soop M., Duxbury H., Agwunobi A.O., Gibson J.M., Hopkins S.J., Childs C., et al. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am J Physiol Endocrinol Metab 282 (2002) E1276-E1285
26. Dandona P., Chaudhuri A., Ghanim H., and Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol 99 (2007) 15B-26B
27. Tentolouris N., Liatis S., and Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci 1083 (2006) 129-152
28. O'Riordain M.G., Ross J.A., Fearon K.C.H., Maingay J., Farouk M., Garden J., et al. Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol Endocrinol Metab 269 (1995) E323-E330
29. Ferri C., Desideri G., Baldoncini R., Bellini C., De Angelis C., Mazzocchi C., et al. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes 47 4 (1998) 660-667
30. Haller H., Park J.K., Dragun D., Lippoldt A., and Luft F.C. Leukocyte infiltration and ICAM-1 expression in two-kidney one-clip hypertension. Nephrol Dial Transplant 12 5 (1997) 899-903
31. Goonasekera C.D., Shah V., Rees D.D., and Dillon M.J. Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma?. Blood Press 9 1 (2000) 16-21
32. Boulbou M.S., Koukoulis G.N., Makri E.D., Petinaki E.A., Gourgoulianis K.I., and Germenis A.E. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int J Cardiol 98 1 (2005) 39-44
33. Cardillo C., Mettimano M., Mores N., Koh K.K., Campia U., and Panza J.A. Plasma levels of cell adhesion molecules during hyperinsulinemia and modulation of vasoactive mediators. Vasc Med 9 3 (2004) 185-188
34. Blüher M., Unger R., Rassoul F., Richter V., and Paschke R. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type II diabetes. Diabetologia 45 2 (2002) 210-216
35. Madonna R., Pandolfi A., Massaro M., Consoli A., and De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 47 (2004) 532-536
36. Garanty-Bogacka B., Syrenicz M., Syrenicz A., Gebala A., and Walczak M. Relation of acute-phase reaction and endothelial activation to insulin resistance and adiposity in obese children and adolescents. Neuro Endocrinol Lett 26 5 (2005) 473-479
37. Lee S., Gungor N., Bacha F., and Arslanian S. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care 30 8 (2007) 2091-2097 Epub 2007 May 2. Erratum in: Diabetes Care. 2007 Oct;30(10):2763]
38. Fu A., and Nair K.S. Age effect on fibrinogen and albumin synthesis in humans. Am J Physiol 275 6 Pt. 1 (1998 Dec) E1023-E1030
39. Jacquemin B., Antoniades C., Nyberg F., Plana E., Müller M., Greven S., et al. Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study. J Am Coll Cardiol 52 11 (2008) 941-952